Question 1

Who are the top researchers at OncoTherapy Science (Japan)?

Accepted Answer

Ranked on the quality score, Yo Matsuo, Tetsuro Hikichi and Allan Goff lead among researchers whose main affiliation is OncoTherapy Science (Japan).

Question 2

What are the most cited papers from OncoTherapy Science (Japan)?

Accepted Answer

The most cited paper from OncoTherapy Science (Japan) is "Functional analysis of Arabidopsis NCED6 and NCED9 genes indicates that ABA synthesized in the endosperm is involved in the induction of seed dormancy" (Valérie Lefebvre, Helen North, Anne Frey et al., 2006), with 504 citations. Next come "Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS" (156) and "Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer" (155).

Question 3

Which research topics does OncoTherapy Science (Japan) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Acute Myeloid Leukemia Research and Protein Degradation and Inhibitors.

Question 4

Which keywords describe research at OncoTherapy Science (Japan)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Immunotherapy, Apoptosis, Antigen Presentation, Regulation, Oxidative Stress, Innate Immunity and Immunity.

Question 5

Which fields of science does OncoTherapy Science (Japan) work in?

Accepted Answer

In all years, 43% of research at OncoTherapy Science (Japan) is in Life Sciences, 28% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (29%), Medicine (28%), Immunology and Microbiology (12%). It does 2.3× the world's share of Life Sciences.

Question 6

Is OncoTherapy Science (Japan)'s research output growing?

Accepted Answer

Output in 2022-2025 was 55% lower than in 2018-2021.